Login to Your Account

Pharma: Clinic Roundup

Tuesday, October 16, 2012
• H. Lundbeck A/S, of Copenhagen, Denmark, reported post hoc analyses at the European College of Neuropsychopharmacology meeting in Vienna, Austria, showing that asenapine achieved significant control of mixed episodes in bipolar I disorder compared to placebo. Asenapine is a tetracyclic antipsychotic therapy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription